» Articles » PMID: 181760

Antiviral Activity of an Extract of Brucella Abortus: Induction of Interferon and Immunopotentiation of Host Resistance

Overview
Date 1976 Jul 1
PMID 181760
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Antitumor activity of a Brucella abortus preparation.

Keleti G, Feingold D, Youngner J Infect Immun. 1977; 15(3):846-9.

PMID: 404249 PMC: 421450. DOI: 10.1128/iai.15.3.846-849.1977.


Peritoneal macrophage activation indicated by enhanced chemiluminescence.

Schleupner C, Glasgow L Infect Immun. 1978; 21(3):886-95.

PMID: 213391 PMC: 422080. DOI: 10.1128/iai.21.3.886-895.1978.


Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine.

Lodmell D, Ewalt L Infect Immun. 1978; 19(1):225-30.

PMID: 203533 PMC: 414071. DOI: 10.1128/iai.19.1.225-230.1978.


Antiviral activity of BL-3849A, a low-molecular-weight oral interferon inducer.

Kern E, Hamilton J, OVERALL J, Glasgow L Antimicrob Agents Chemother. 1976; 10(4):691-6.

PMID: 185953 PMC: 429816. DOI: 10.1128/AAC.10.4.691.


Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophages.

Glasgow L, Crane Jr J, Schleupner C, Kern E, Youngner J, Feingold D Infect Immun. 1979; 23(1):19-26.

PMID: 106004 PMC: 550682. DOI: 10.1128/iai.23.1.19-26.1979.